Exact Sciences
EXAS
#1386
Rank
NZ$21.15 B
Marketcap
$114.49
Share price
2.34%
Change (1 day)
-9.41%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -NZ$0.26 B

According to Exact Sciences's latest financial reports the company's current earnings (TTM) are -NZ$0.26 B. In 2023 the company made an earning of -NZ$0.3 B an increase over its 2022 earnings that were of -NZ$1 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.26 B-14.99%
2023 -NZ$0.3 B-69.98%
2022 -NZ$1 B-25.55%
2021 -NZ$1.35 B1.68%
2020 -NZ$1.32 B271.17%
2019 -NZ$0.36 B58.99%
2018 -NZ$0.23 B20.89%
2017 -NZ$0.19 B-30.95%
2016 -NZ$0.27 B5.09%
2015 -NZ$0.26 B57.24%
2014 -NZ$0.17 B116.53%
2013 -NZ$74.84 M
2011 -NZ$46.59 M143.73%
2010 -NZ$19.12 M27.85%
2009 -NZ$14.96 M0.27%
2008 -NZ$14.92 M-20.95%
2007 -NZ$18.87 M-13.53%
2006 -NZ$21.82 M-10.07%
2005 -NZ$24.26 M-21.81%
2004 -NZ$31.03 M-33.44%
2003 -NZ$46.62 M-6.51%
2002 -NZ$49.86 M17.95%
2001 -NZ$42.27 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.25 B-0.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.10 B-142.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$88.56 M-64.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$56.52 M-77.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.91 B-4,458.48%๐Ÿ‡ซ๐Ÿ‡ท France